Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|October 2, 2003
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trialF M Wachters, J W G Van Putten, H Kramer, et al.
Critical Reviews in Oncology/Hematology|November 5, 2002
Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategiesC S M Oude Nijhuis, S M G J Daenen, E Vellenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III studyB Biesma, A N M Wymenga, A Vincent, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2013
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancerT Ciuleanu, C-M Tsai, C-J Tsao, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patientsC S M Oude Nijhuis, J A Gietema, E Vellenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)H J M Groen, M A Socinski, F Grossi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy RegistryH J M Smit, J Aerts, M van den Heuvel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†A-M C Dingemans, H J M Groen, G J M Herder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumorsJ A Gietema, R Hoekstra, F Y F L de Vos, et al.
Pageof 7